Company research
Oncternal Therapeutics, Inc.
CIK 1260990Updated Nov 16, 2026
Securities
Historical securities (1)
ONCT · NASDAQ · equity · closed Dec 2, 2024Name history
GTX INC /DE/ · through Jun 11, 2019GTX INC/TN · through Jan 15, 2004
ONCT price & chart
Historical security
This listing closed Dec 2, 2024. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2023 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 36,729,000Source | 68,651,000Source | 93,585,000Source | 118,809,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 6,697,000Source | 37,142,000Source | 90,765,000Source | 116,737,000Source |
| Assets, CurrentUSD | 36,059,000Source | 67,290,000Source | 92,853,000Source | 118,003,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,804,000Source | 3,566,000Source | 2,088,000Source | — |
| Operating Lease, Right-of-Use AssetUSD | 258,000Source | 87,000Source | 75,000Source | 40,000Source |
| Other Assets, NoncurrentUSD | 412,000Source | 1,274,000Source | 657,000Source | 766,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 6,677,000Source | — | — | — |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | — | — |
| Common Stock, Value, IssuedUSD | 3,000Source | 57,000Source | 49,000Source | 49,000Source |
| Additional Paid in CapitalUSD | 227,825,000Source | 219,203,000Source | 202,201,000Source | 195,699,000Source |
| Retained Earnings (Accumulated Deficit)USD | -197,779,000Source | -158,300,000Source | -114,130,000Source | -82,797,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 3,000Source | 9,000Source | — | — |
| Stockholders' Equity Attributable to ParentUSD | 30,052,000Source | 60,969,000Source | 88,120,000Source | 112,951,000Source |
| Liabilities and EquityUSD | 36,729,000Source | 68,651,000Source | 93,585,000Source | 118,809,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 5,198,000Source | 7,682,000Source | 5,465,000Source | 5,858,000Source |
| Operating Lease, Liability, CurrentUSD | 173,000Source | 87,000Source | 75,000Source | 40,000Source |
| Accounts Payable, CurrentUSD | 1,148,000Source | 2,917,000Source | 1,959,000Source | 1,143,000Source |
| Operating Lease, Liability, NoncurrentUSD | 145,000Source | — | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 3,877,000Source | 4,678,000Source | 3,431,000Source | 3,042,000Source |
| Short-term InvestmentsUSD | 27,558,000Source | 26,582,000Source | — | — |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -39,479,000Source | -44,170,000Source | -31,333,000Source | -17,225,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 7,500,000Source | 7,431,000Source | 5,875,000Source | 1,556,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | -1,769,000Source | 958,000Source | 816,000Source | 272,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -32,164,000Source | -36,704,000Source | -26,589,000Source | -17,495,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 651,000Source | -26,498,000Source | — | — |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 156,000Source | 3,000Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 1,068,000Source | 9,579,000Source | 617,000Source | 114,181,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -30,445,000Source | -53,623,000Source | -25,972,000Source | 96,686,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 7,500,000Source | 7,431,000Source | 5,875,000Source | 1,556,000Source |
| General and Administrative ExpenseUSD | 12,746,000Source | 13,457,000Source | 11,595,000Source | 8,373,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | — | — |
| Investment Income, InterestUSD | 2,235,000Source | 777,000Source | 33,000Source | 16,000Source |
| Net Income (Loss) Attributable to ParentUSD | -39,479,000Source | -44,170,000Source | -31,333,000Source | -17,225,000Source |
| Operating ExpensesUSD | 42,499,000Source | 46,437,000Source | 35,681,000Source | 20,917,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 33,000Source | 317,000Source |
| Proceeds from Issuance of Common StockUSD | 1,224,000Source | 9,582,000Source | — | 113,876,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | 301,000Source |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total RevenueUSD | 785,000Source | 1,490,000Source | 4,315,000Source | 3,375,000Source |
| Operating Income (Loss)USD | -41,714,000Source | -44,947,000Source | -31,366,000Source | -17,542,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 33,000Source | 317,000Source |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -39,479,000Source | -44,170,000Source | -31,333,000Source | -17,225,000Source |
| Earnings Per Share, BasicUSD per share | -13.43Source | -0.84Source | — | — |
| Earnings Per Share, DilutedUSD per share | -13.43Source | -0.84Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 2,940,000Source | 52,594,000Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 2,940,000Source | 52,594,000Source | — | — |
| Additional Financial Items | ||||
| General and Administrative ExpenseUSD | 12,746,000Source | 13,457,000Source | 11,595,000Source | 8,373,000Source |
| Investment Income, InterestUSD | 2,235,000Source | 777,000Source | 33,000Source | 16,000Source |
| Operating ExpensesUSD | 42,499,000Source | 46,437,000Source | 35,681,000Source | 20,917,000Source |
| Research and Development ExpenseUSD | — | 0Source | 0Source | 0Source |